Cellebrite (CLBT) announced the general availability of Generative Artificial Intelligence capabilities within Guardian, the Company’s ...

Cellebrite (NASDAQ: CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced the general availability of Generative Artificial Intelligence ...

TYSONS CORNER, Va. and PETAH TIKVA, Israel, Feb. 06, 2025(NASDAQ: CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced the general avai ...

For deeper insights into Cellebrite's valuation and growth potential, investors can access the comprehensive Pro Research Report, available exclusively to InvestingPro subscribers. In other recent ...

In recent trading, shares of Cellebrite DI Ltd (Symbol: CLBT) have crossed above the average analyst 12-month target price of $23.29, changing hands for $23.87/share. When a stock reaches the ...

Cellebrite DI Ltd. engages in the provision of digital investigative solutions for the public and private sectors, empowering organizations in mastering the complexities of legally sanctioned ...

Using the 2 Stage Free Cash Flow to Equity, Cellebrite DI fair value estimate is US$19.57 With US$21.81 share price, Cellebrite DI appears to be trading close to its estimated fair value Our fair ...

Cellebrite’s (Nasdaq: CLBT) mission is to enable its customers to protect and save lives, accelerate justice and preserve privacy in communities around the world. We are a global leader in ...

Cellebrite’s 2024 North American Federal Industry Trends whitepaper highlights specialized insights gleaned from 183 investigators, agency managers and digital forensic examiners across large ...